福元医药
(601089)
| 流通市值：119.38亿 | | | 总市值：119.38亿 |
| 流通股本：4.80亿 | | | 总股本：4.80亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,589,127,104.22 | 1,511,645,417.79 | 1,004,940,414.02 | 794,067,803.65 |
| 交易性金融资产 | 478,800,000 | 511,000,000 | 1,240,000,000 | 1,579,000,000 |
| 应收票据及应收账款 | 365,497,507.9 | 360,179,940.02 | 353,475,377.93 | 354,656,351.21 |
| 应收账款 | 365,497,507.9 | 360,179,940.02 | 353,475,377.93 | 354,656,351.21 |
| 应收款项融资 | 77,806,625.26 | 67,960,399.2 | 84,887,204.79 | 97,425,194.26 |
| 预付款项 | 51,336,779.63 | 51,106,052.86 | 35,848,453.37 | 24,504,710.43 |
| 其他应收款合计 | 1,496,955.45 | 1,497,146.8 | 3,095,716.46 | 1,201,965.77 |
| 存货 | 383,407,211.04 | 360,237,405.77 | 329,944,868.46 | 347,555,462.41 |
| 其他流动资产 | 10,877,931.66 | 3,765,038.43 | 4,057,927.94 | 2,751,027.04 |
| 流动资产合计 | 2,958,350,115.16 | 2,867,391,400.87 | 3,056,249,962.97 | 3,201,162,514.77 |
| 非流动资产: | | | | |
| 固定资产 | 1,434,500,096.34 | 1,329,452,897.36 | 1,284,606,240.34 | 673,167,008.85 |
| 在建工程 | 189,364,581.79 | 280,067,746.26 | 315,701,323.31 | 719,151,066.27 |
| 使用权资产 | 28,940,355.32 | 31,281,896.6 | 30,792,229.66 | 33,477,211.76 |
| 无形资产 | 135,367,247.97 | 138,536,024.94 | 141,450,842.73 | 139,209,080.8 |
| 长期待摊费用 | 15,333,238.87 | 17,516,364.22 | 20,011,761.55 | 21,816,310.33 |
| 递延所得税资产 | 4,287,809.63 | 3,023,601.88 | 2,730,861.7 | 3,308,072.57 |
| 其他非流动资产 | 26,865,089.56 | 23,422,239.41 | 17,576,621.09 | 25,341,119.71 |
| 非流动资产合计 | 1,834,658,419.48 | 1,823,300,770.67 | 1,812,869,880.38 | 1,615,469,870.29 |
| 资产总计 | 4,793,008,534.64 | 4,690,692,171.54 | 4,869,119,843.35 | 4,816,632,385.06 |
| 流动负债: | | | | |
| 短期借款 | - | - | 10,011,166.67 | 40,033,533.34 |
| 应付票据及应付账款 | 227,633,390.69 | 231,565,144.12 | 266,994,507.71 | 286,760,509.03 |
| 应付账款 | 227,633,390.69 | 231,565,144.12 | 266,994,507.71 | 286,760,509.03 |
| 预收款项 | 27,799.97 | 43,499.98 | 60,099.99 | 82,800 |
| 合同负债 | 60,254,333.99 | 49,910,646.9 | 38,829,450.66 | 36,591,930.56 |
| 应付职工薪酬 | 132,427,241.31 | 114,679,458.7 | 82,273,629.15 | 143,641,602.55 |
| 应交税费 | 42,565,633.63 | 30,510,231.21 | 38,444,662.52 | 46,120,302.17 |
| 其他应付款合计 | 500,490,784.17 | 571,193,234.59 | 636,822,516.28 | 589,762,121.35 |
| 一年内到期的非流动负债 | 16,968,254.04 | 18,368,100.72 | 14,475,363.15 | 14,334,663.9 |
| 其他流动负债 | 41,159,572.26 | 33,571,674.17 | 28,913,268.53 | 32,612,085.46 |
| 流动负债合计 | 1,021,527,010.06 | 1,049,841,990.39 | 1,116,824,664.66 | 1,189,939,548.36 |
| 非流动负债: | | | | |
| 租赁负债 | 11,662,794.94 | 14,093,767.63 | 16,131,474.14 | 20,793,200.3 |
| 递延收益 | 42,660,316.03 | 34,452,140.72 | 34,111,287.99 | 34,490,321.55 |
| 递延所得税负债 | 17,834,118.27 | 2,245,269.58 | 15,607,122.41 | 15,327,927.35 |
| 非流动负债合计 | 72,157,229.24 | 50,791,177.93 | 65,849,884.54 | 70,611,449.2 |
| 负债合计 | 1,093,684,239.3 | 1,100,633,168.32 | 1,182,674,549.2 | 1,260,550,997.56 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 480,000,000 | 480,000,000 | 480,000,000 | 480,000,000 |
| 资本公积 | 1,662,392,718.51 | 1,662,392,718.51 | 1,662,392,718.51 | 1,662,392,718.51 |
| 减:库存股 | 176,186,608.79 | 176,186,608.79 | 176,186,608.79 | 176,186,608.79 |
| 专项储备 | 10,430,527.19 | 10,483,101.78 | 10,536,073.51 | 10,977,571.6 |
| 盈余公积 | 192,060,121.76 | 192,060,121.76 | 192,060,121.76 | 192,060,121.76 |
| 未分配利润 | 1,516,652,618.07 | 1,409,179,874.66 | 1,505,945,270.24 | 1,375,312,235.02 |
| 归属于母公司股东权益合计 | 3,685,349,376.74 | 3,577,929,207.92 | 3,674,747,575.23 | 3,544,556,038.1 |
| 少数股东权益 | 13,974,918.6 | 12,129,795.3 | 11,697,718.92 | 11,525,349.4 |
| 股东权益合计 | 3,699,324,295.34 | 3,590,059,003.22 | 3,686,445,294.15 | 3,556,081,387.5 |
| 负债和股东权益合计 | 4,793,008,534.64 | 4,690,692,171.54 | 4,869,119,843.35 | 4,816,632,385.06 |
| 公告日期 | 2025-10-30 | 2025-08-19 | 2025-04-30 | 2025-04-01 |
| 审计意见(境内) | | | | 标准无保留意见 |